PuSH - Publication Server of Helmholtz Zentrum München

Sun, J.* ; Zhao, T. ; Zhao, D.* ; Qi, X.* ; Bao, X. ; Shi, R.* ; Su, C.*

Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients.

Ther. Adv. Med. Oncol. 12, 1-14 (2020)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Background: Patients with early-stage lung adenocarcinoma (LUAD) exhibit significant heterogeneity in overall survival. The current tumour-node-metastasis staging system is insufficient to provide precise prediction for prognosis. Methods: We quantified the levels of various hallmarks of cancer and identified hypoxia as the primary risk factor for overall survival in early-stage LUAD. Different bioinformatic and statistical methods were combined to construct a robust hypoxia-related gene signature for prognosis. Furthermore, a decision tree and a nomogram were constructed based on the gene signature and clinicopathological features to improve risk stratification and quantify risk assessment for individual patients. Results: The hypoxia-related gene signature discriminated high-risk patients at an early stage in our investigated cohorts. Survival analyses demonstrated that our gene signature served as an independent risk factor for overall survival. The decision tree identified risk subgroups powerfully, and the nomogram exhibited high accuracy. Conclusions: Our study might contribute to the optimization of risk stratification for survival and personalized management of early-stage LUAD.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.852
1.780
13
27
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Early-stage Lung Adenocarcinoma ; Gene Signature ; Hypoxia ; Prognosis ; Therapeutic Resistance; Cancer; Prognosis; Progression; Metastasis; Resistance
Language english
Publication Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 1758-8340
e-ISSN 1758-8359
Quellenangaben Volume: 12, Issue: , Pages: 1-14 Article Number: , Supplement: ,
Publisher Sage
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)
Institute of Radiation Biology (ISB)
POF-Topic(s) 30202 - Environmental Health
Research field(s) Genetics and Epidemiology
Radiation Sciences
PSP Element(s) G-504000-008
G-500200-001
Scopus ID 85087407228
PubMed ID 32655701
Erfassungsdatum 2020-07-28